Incidence of Headache Following an Unintentional Dural Puncture

NACompletedINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

March 1, 2019

Study Completion Date

March 1, 2019

Conditions
Postdural Puncture HeadachePost-Lumbar Puncture HeadacheCerebrospinal Fluid Leaks
Interventions
DRUG

Morphine

The drug will be prepared in tuberculin syringes. After thoroughly sanitizing the catheter port with a Chloroprep wipe and allowing adequate time for drying of the Chloroprep, the anesthesiologist will first attach a 3-mL syringe to the catheter port and aspirate to a volume of 1 mL. This syringe will then be removed from the port. The study drug will then be administered through the intrathecal catheter via the tuberculin syringe. The 3-mL syringe containing the aspirate will then be injected via the catheter, effectively flushing the study drug through the catheter. The intrathecal catheter will be removed immediately following the injection.

DRUG

Saline

The drug will be prepared in tuberculin syringes. After thoroughly sanitizing the catheter port with a Chloroprep wipe and allowing adequate time for drying of the Chloroprep, the anesthesiologist will first attach a 3-mL syringe to the catheter port and aspirate to a volume of 1 mL. This syringe will then be removed from the port. The study drug will then be administered through the intrathecal catheter via the tuberculin syringe. The 3-mL syringe containing the aspirate will then be injected via the catheter, effectively flushing the study drug through the catheter. The intrathecal catheter will be removed immediately following the injection.

Trial Locations (1)

60611

Northwestern Memorial Hospital, Chicago

All Listed Sponsors
lead

Northwestern University

OTHER

NCT01977898 - Incidence of Headache Following an Unintentional Dural Puncture | Biotech Hunter | Biotech Hunter